Today: 10 June 2026
Microsoft stock slides on Trump tariff uncertainty as Wall Street turns cautious
23 February 2026
2 mins read

Microsoft stock slides on Trump tariff uncertainty as Wall Street turns cautious

New York, Feb 23, 2026, 10:14 EST — Regular session.

  • Microsoft slipped around 2% shortly after the open, part of a wider retreat among major tech names.
  • Investors stayed cautious, unsettled by renewed uncertainty over U.S. tariffs.
  • Nvidia’s results, due Feb. 25, are shaping up to be a major checkpoint for traders betting on AI-linked stocks.

Microsoft Corp shares slipped 2.2% to $388.60 during early Monday trading, moving down alongside other mega-cap tech stocks as investors faced fresh doubts around U.S. trade policy.

Microsoft (MSFT.O) carries significant heft in the big U.S. indexes, meaning even small swings have an outsized effect on the broader market. The stock now serves as a barometer for investor anxiety over the pace of corporate spending on cloud computing and artificial intelligence.

Stocks stumbled out of the gate after President Donald Trump rolled out a fresh 15% blanket tariff, coming directly on the heels of a U.S. Supreme Court decision that invalidated his previous wider tariffs. The Dow Jones Industrial Average started down 89.4 points, with the S&P 500 easing 0.12% and the Nasdaq off 0.20%.

The Supreme Court tossed out Trump’s emergency tariffs on Friday. Within hours, he rolled out a 10% tariff on all other countries, bumping that up to 15% by Saturday. “The tariff landscape is now more uncertain than before,” said Rodrigo Catril, senior FX strategist at National Australia Bank. After the weekend’s move, the Yale Budget Lab put the average effective tariff at 13.7%. The 15% rate, according to the group, should expire after 150 days, citing the Trade Act of 1974. Reuters

Tariff chatter couldn’t come at a trickier moment for Microsoft. The company’s got hardware—think Surface PCs, Xbox consoles—moving through its pipeline, while it’s also channeling big investments into far-flung data centers built on expansive global supply chains.

Investors are weighing Microsoft’s latest changes in its gaming leadership. Phil Spencer, who has led the gaming unit, is stepping down, with insider Asha Sharma taking over as CEO. Xbox president and COO Sarah Bond is also departing. “Since then we’ve been talking about succession planning,” CEO Satya Nadella said. D.A. Davidson’s Gil Luria notes this leadership shuffle is happening as AI “becomes a bigger element in game development.” Investing.com

Since late January, Microsoft shares have seen some choppy moves. The company pointed to record capex—think data centers and gear—as it ramps up for AI, but investors weren’t sold on the cloud revenue growth. After the report, the stock took a hit.

The stock kicked off Monday at $395.00, then swung between $387.41 on the low end and $397.12 at its peak. Trading volume topped 8 million shares.

Nvidia’s earnings, coming up Wednesday, Feb. 25, are the next big test for AI-tied stocks, with traders sizing up the report as a pulse check for the whole sector.

The risk cuts both ways. More tariff surprises might keep volatility on edge. On the other hand, if Nvidia delivers a weaker update, it could reignite concerns that AI investment is outpacing what the market actually needs right now.

Investors are set to parse out specifics on the 15% tariff’s rollout, with eyes turning next to Nvidia’s Feb. 25 results for signals on Microsoft and the rest of the big tech group.

Stock Market Today

  • December 2028 Options Now Trade for Keel Infrastructure (KEEL) With High YieldBoost Potential
    June 10, 2026, 12:27 PM EDT. Investors can now trade December 2028 options for Keel Infrastructure Corp (KEEL), offering a long-dated opportunity with 919 days to expiration. A notable call option at a $10 strike price trades with a $2.40 bid, translating to a potential 121.43% return if the shares are called away from the current $5.60 price. The $10 strike is about 79% out-of-the-money, implying a 19% chance the option expires worthless, allowing investors to keep the premium, which yields a 42.86% return or 17.02% annualized YieldBoost. The call's implied volatility is 136%, outperforming the stock's actual trailing volatility of 108%. This presents elevated time value, appealing for covered call strategies seeking enhanced premiums over nearer-term options.

Latest articles

Ford Shares Slide as F-150 Aluminum Constraint Eases

Ford Shares Slide as F-150 Aluminum Constraint Eases

10 June 2026
Ford shares slid 3.2% to $14.47 despite Novelis restarting its Oswego aluminum plant, a key F-Series supplier, as investors now focus on how quickly supply ramps up to cut costs and boost production after months of disruption that forced Ford to cut its 2025 profit forecast and warn of up to $2 billion in charges.
Broadcom Shares Slip After $35 Billion AI Transaction, Guidance Jitters Linger

Broadcom Shares Slip After $35 Billion AI Transaction, Guidance Jitters Linger

10 June 2026
Broadcom shares plunged 4% to $376.42 despite unveiling a $35 billion AI infrastructure deal with Apollo and Blackstone, as investors fixated on last week’s softer-than-expected AI chip revenue guidance and ongoing concerns over high valuation, customer concentration, and margin risks tied to new AI financing models.
Palantir CEO Karp takes aim at AI spend by Anthropic, OpenAI

Palantir CEO Karp takes aim at AI spend by Anthropic, OpenAI

10 June 2026
Palantir shares edged up less than 1% to $132.66 after CEO Alex Karp told CNBC that enterprise customers are privately “unhappy” with frontier AI labs’ billing practices, as AI buyers face “sticker shock” and cost savings lag, while Palantir pitches its software and embedded engineers as a solution amid ongoing scrutiny of its NHS contract in Britain.
CrowdStrike stock steadies premarket after Anthropic’s Claude Code Security rattles cyber shares
Previous Story

CrowdStrike stock steadies premarket after Anthropic’s Claude Code Security rattles cyber shares

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop